Patrik Jeanmonod

Chief Financial Officer

US·SEC (Form 4)

Cytek Biosciences, Inc.

Cumul. flow

Total declarations

Company

▲ Purchases (0 ops.)

—

▼ Sales (18 ops.)

€554k

Latest filing published 13 Mar 2024 for Cytek Biosciences, Inc..

Filing timeline

BuySale

Patrik Jeanmonod

Insider track record

Disclosed buys

Disclosed sells

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Patrik Jeanmonod: trading record in brief

All filings by Patrik Jeanmonod on record concern Cytek Biosciences, Inc., in the capacity of finance chief. Between 18 May 2022 and 11 March 2024, the trades on record add up to 43 filings.

On the market, this insider has only sold: 18 sales, €554k in total. Besides market trades, the filings include 12 share grants and 13 option exercises.

Most recently, on 13 March 2024, the filings show a share grant worth €13k in Cytek Biosciences, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Patrik Jeanmonod

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Cytek Biosciences, Inc. (US)

Declarations28 total

◇
Patrik Jeanmonod
CHIEF FINANCIAL OFFICERExecutives11 Mar 2024Cytek Biosciences, Inc.
0SEC
4,908 sharesCommon StockSEC:0001415889-24-007863:0
◇
Patrik Jeanmonod
CHIEF FINANCIAL OFFICERExecutives20 Feb 2024Cytek Biosciences, Inc.
0SEC
1,752 sharesCommon StockSEC:0001415889-24-004886:0
▼
Patrik Jeanmonod
Chief Financial OfficerExecutives26 Dec 2023Cytek Biosciences, Inc.
28,500 USD31SEC
3,000 shares@ US$9.504.5% of flowCommon StockSEC:0001209191-23-059819:0
▼
Patrik Jeanmonod
Chief Financial OfficerExecutives24 Nov 2023Cytek Biosciences, Inc.
20,820 USD34SEC
3,000 shares@ US$6.943.3% of flowCommon StockSEC:0001209191-23-056733:0
◇
Patrik Jeanmonod
Chief Financial OfficerExecutives18 Nov 2023Cytek Biosciences, Inc.
0SEC
1,752 sharesCommon StockSEC:0001209191-23-056349:0
▼
Patrik Jeanmonod
Chief Financial OfficerExecutives24 Oct 2023Cytek Biosciences, Inc.
14,040 USD34SEC
3,000 shares@ US$4.682.3% of flowCommon StockSEC:0001209191-23-053595:0
▼
Patrik Jeanmonod
Chief Financial OfficerExecutives25 Sept 2023Cytek Biosciences, Inc.
19,140 USD34SEC
3,000 shares@ US$6.383.5% of flowCommon StockSEC:0001209191-23-050611:0
▼
Patrik Jeanmonod
Chief Financial OfficerExecutives24 Aug 2023Cytek Biosciences, Inc.
23,070 USD34SEC
3,000 shares@ US$7.693.7% of flowCommon StockSEC:0001209191-23-047533:0
◇
Patrik Jeanmonod
Chief Financial OfficerExecutives18 Aug 2023Cytek Biosciences, Inc.
0SEC
1,752 sharesCommon StockSEC:0001209191-23-046833:0
▼
Patrik Jeanmonod
Chief Financial OfficerExecutives24 Jul 2023Cytek Biosciences, Inc.
27,510 USD34SEC
3,000 shares@ US$9.174.4% of flowCommon StockSEC:0001209191-23-043340:0
▼
Patrik Jeanmonod
Chief Financial OfficerExecutives26 Jun 2023Cytek Biosciences, Inc.
23,880 USD34SEC
3,000 shares@ US$7.963.8% of flowCommon StockSEC:0001209191-23-039967:0
▼
Patrik Jeanmonod
Chief Financial OfficerExecutives24 May 2023Cytek Biosciences, Inc.
23,280 USD34SEC
3,000 shares@ US$7.763.8% of flowCommon StockSEC:0001209191-23-032259:0
◇
Patrik Jeanmonod
Chief Financial OfficerExecutives18 May 2023Cytek Biosciences, Inc.
0SEC
1,752 sharesCommon StockSEC:0001209191-23-031264:0
▼
Patrik Jeanmonod
Chief Financial OfficerExecutives24 Apr 2023Cytek Biosciences, Inc.
30,720 USD34SEC
3,000 shares@ US$10.244.9% of flowCommon StockSEC:0001209191-23-025617:0
▼
Patrik Jeanmonod
Chief Financial OfficerExecutives24 Mar 2023Cytek Biosciences, Inc.
24,990 USD34SEC
3,000 shares@ US$8.334.0% of flowCommon StockSEC:0001209191-23-021140:0
▼
Patrik Jeanmonod
Chief Financial OfficerExecutives24 Feb 2023Cytek Biosciences, Inc.
33,150 USD35SEC
3,000 shares@ US$11.055.5% of flowCommon StockSEC:0001209191-23-013889:0
◇
Patrik Jeanmonod
Chief Financial OfficerExecutives8 Sept 2022Cytek Biosciences, Inc.
16,000 USD19SEC
40,000 shares@ US$0.402.8% of flowCommon StockSEC:0001209191-23-012351:0
◇
Patrik Jeanmonod
Chief Financial OfficerExecutives21 Feb 2023Cytek Biosciences, Inc.
0SEC
1,752 sharesCommon StockSEC:0001209191-23-012352:0
▼
Patrik Jeanmonod
Chief Financial OfficerExecutives24 Jan 2023Cytek Biosciences, Inc.
38,675 USD35SEC
3,500 shares@ US$11.056.2% of flowCommon StockSEC:0001209191-23-004922:0
▼
Patrik Jeanmonod
Chief Financial OfficerExecutives27 Dec 2022Cytek Biosciences, Inc.
34,195 USD35SEC
3,500 shares@ US$9.775.6% of flowCommon StockSEC:0001209191-22-062882:0
▼
Patrik Jeanmonod
Chief Financial OfficerExecutives25 Nov 2022Cytek Biosciences, Inc.
50,050 USD35SEC
3,500 shares@ US$14.308.4% of flowCommon StockSEC:0001209191-22-058890:0
◇
Patrik Jeanmonod
Chief Financial OfficerExecutives18 Nov 2022Cytek Biosciences, Inc.
0SEC
1,752 sharesCommon StockSEC:0001209191-22-058467:0
▼
Patrik Jeanmonod
Chief Financial OfficerExecutives24 Oct 2022Cytek Biosciences, Inc.
53,060 USD35SEC
3,500 shares@ US$15.169.4% of flowCommon StockSEC:0001209191-22-054563:0
▼
Patrik Jeanmonod
Chief Financial OfficerExecutives26 Sept 2022Cytek Biosciences, Inc.
44,205 USD35SEC
3,500 shares@ US$12.638.1% of flowCommon StockSEC:0001209191-22-051488:0
▼
Patrik Jeanmonod
Chief Financial OfficerExecutives24 Aug 2022Cytek Biosciences, Inc.
47,075 USD35SEC
3,500 shares@ US$13.458.3% of flowCommon StockSEC:0001209191-22-047576:0

25 of 28 declarations

Patrik Jeanmonod

Insider track record

Patrik Jeanmonod: trading record in brief

Companies and markets linked to Patrik Jeanmonod

Similar companies

Related executives